Coloplast A/S (CLPBY)
OTCMKTS · Delayed Price · Currency is USD
7.54
-0.05 (-0.66%)
At close: Nov 9, 2026
Coloplast Income Statement
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| 28,941 | 27,874 | 27,030 | 24,500 | 22,579 | |
Revenue Growth | 3.83% | 3.12% | 10.33% | 8.51% | 16.23% |
Cost of Revenue | 9,695 | 8,929 | 8,761 | 8,172 | 7,050 |
Gross Profit | 19,246 | 18,945 | 18,269 | 16,328 | 15,529 |
Selling, General & Admin | 10,815 | 10,420 | 10,069 | 8,633 | 7,802 |
Research & Development | 1,067 | 946 | 913 | 872 | 866 |
Other Operating Expenses | -83 | -140 | -22 | -25 | -56 |
Operating Expenses | 11,799 | 11,224 | 10,960 | 9,479 | 8,610 |
Operating Income | 7,447 | 7,721 | 7,309 | 6,849 | 6,919 |
Interest Expense | -658 | -753 | -795 | -638 | -172 |
Interest & Investment Income | 96 | 102 | 155 | 111 | 39 |
Currency Exchange Gain (Loss) | 188 | -231 | -218 | -178 | -134 |
Other Non Operating Income (Expenses) | 15 | -118 | -85 | -78 | -66 |
EBT Excluding Unusual Items | 7,088 | 6,721 | 6,366 | 6,066 | 6,586 |
Merger & Restructuring Charges | -195 | -376 | -89 | -118 | -171 |
Impairment of Goodwill | -3,000 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | -49 | -23 | -3 | -7 |
Legal Settlements | - | - | - | -200 | -300 |
Other Unusual Items | -44 | -139 | 141 | 280 | 19 |
Pretax Income | 3,849 | 6,157 | 6,395 | 6,025 | 6,127 |
Income Tax Expense | 775 | 2,521 | 1,343 | 1,242 | 1,421 |
Net Income | 3,074 | 3,636 | 5,052 | 4,783 | 4,706 |
Net Income to Common | 3,074 | 3,636 | 5,052 | 4,783 | 4,706 |
Net Income Growth | -15.46% | -28.03% | 5.62% | 1.64% | -2.47% |
Shares Outstanding (Basic) | 225 | 225 | 225 | 215 | 213 |
Shares Outstanding (Diluted) | 225 | 225 | 225 | 216 | 213 |
Shares Change | - | 0.22% | 4.36% | 1.27% | -0.19% |
EPS (Basic) | 13.64 | 16.13 | 22.46 | 22.21 | 22.15 |
EPS (Diluted) | 13.64 | 16.13 | 22.46 | 22.20 | 22.11 |
EPS Growth | -15.45% | -28.18% | 1.17% | 0.41% | -2.30% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Free Cash Flow | 6,620 | 5,339 | 1,600 | 3,206 | 4,172 |
Free Cash Flow Per Share | 29.37 | 23.69 | 7.11 | 14.88 | 19.61 |
Dividend Per Share | 23.000 | 23.000 | 22.000 | 21.000 | 20.000 |
Dividend Growth | 0% | 4.54% | 4.76% | 5.00% | 5.26% |
Gross Margin | 66.50% | 67.97% | 67.59% | 66.64% | 68.78% |
Operating Margin | 25.73% | 27.70% | 27.04% | 27.96% | 30.64% |
Profit Margin | 10.62% | 13.04% | 18.69% | 19.52% | 20.84% |
Free Cash Flow Margin | 22.87% | 19.15% | 5.92% | 13.09% | 18.48% |
EBITDA | 8,416 | 8,630 | 8,191 | 7,568 | 7,544 |
EBITDA Margin | 29.08% | 30.96% | 30.30% | 30.89% | 33.41% |
D&A For EBITDA | 969 | 909 | 882 | 719 | 625 |
EBIT | 7,447 | 7,721 | 7,309 | 6,849 | 6,919 |
EBIT Margin | 25.73% | 27.70% | 27.04% | 27.96% | 30.64% |
Effective Tax Rate | 20.14% | 40.95% | 21.00% | 20.61% | 23.19% |